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Novel Biomarker of Abdominal Aortic Aneurysm’”Mr. Koole and his prominent co-authors are thanked for their
interest in our work and the kind words. This Viborg cohorte has
demonstrated many signiﬁcant and unsigniﬁcant associations, so
the risk of some chance ﬁndings is obvious. Mr. Koole et al. propose
to add diabetes mellitus and use of glucocorticoids in the adjusting
multivariate analysis. However, use of glucocorticoids is already
included, and there were not many with diagnosed diabetics
(N ¼ 7). Consequently, IgF remained unchanged and signiﬁcantly
associated with growth rate. We have no variables concerning
physical stress, and we did not measure HbA1c or hsCRP.
The authors further suggest combining IGF-1 and growth rate to
analyse the additive value of using IgF1 instead of only AAA growth
rate to predict need for later surgery. If to be used for such clinical
purposes, growth rate is not optimal as it need longer observation
time. Baseline AAA diameter is more relevant (Initial AAA max
diameter AUC ¼ 0.85, 95% C.I.: 0.77; 0.93), vs (IgF1 and AAA max
diameter combined model: AUC¼ 0.87, 95% C.I.: 0.79; 0.94). Conse-
quently, S-IgF1 doesn’t seem to hold the potential for a clinical
useful biomarker, only as a pathophysiological biomarker.
Finally, the authors ask about the numbers and power of cardio-
vascular events and all cause deaths. The number of cardiovascularDOI of original article: 10.1016/j.ejvs.2011.12.017.ischemic events (N ¼ 29 (25%)) and deaths (N ¼ 37 (32%)) was
lower than later repairs (N ¼ 45), and thus had a lower power. In
addition, these two secondary variables are heterogeneous as all
cause deaths also includes non-cardiovascular deaths and cardio-
vascular events included a number of various hospital discharge
diagnoses due to ischemic events in the brain, heart and legs.
They were not used as a composite endpoint, but separately. Never-
theless, the results concerning overall death and cardiovascular
events may easily be due to misclassiﬁcation bias and/or type
2 errors.
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